Mesenchymal Stem Cells in Cancer Immunotherapy: Promises and Challenges
December 3, 2024
MSCs hold great promise as a therapeutic tool in cancer immunotherapy due to their immunomodulatory properties, tumor-homing abilities, and potential as carriers for delivering therapeutic agents.”BUFFALO, NY - December 3,... read more